Company Lumosa Therapeutics Co., Ltd.

Stocks

6535

TW0006535008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 11/06/2026			5-day change	1st Jan Change
106.50 ^TWD	-1.39%		-9.75%	-45.24%

11/05	Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
23/02	Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Business description: Lumosa Therapeutics Co., Ltd.

LUMOSA THERAPEUTICS CO., LTD. is a Taiwan-based company principally engaged in the development of new drugs. The Company is engaged in the development of new drugs for unmet medical needs in the fields of central nervous system (CNS), oncology, and inflammatory diseases. The Company is engaged in scientific licensing and new drug development under the reSEARCH and DEVELOPMENT model.

Number of employees: 36

Sales by Activity: Lumosa Therapeutics Co., Ltd.

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Biotechnology	1.74Cr	2.66Cr	5.69Cr	3.92Cr	3.58Cr

See all business segments

Geographical breakdown of sales: Lumosa Therapeutics Co., Ltd.

Fiscal Period: December	2021 (TWD)	2022 (TWD)	2023 (TWD)	2024 (TWD)	2025 (TWD)
Taiwan	1.5Cr	2.12Cr	1.54Cr	2.73Cr	2.24Cr
Asia	23.26L	20L	2.56Cr	1.16Cr	1.35Cr
Europe	-	2L	83.46L	-	-
America	-	31.88L	75.56L	2L	-

See all geographic segments

Executive Committee: Lumosa Therapeutics Co., Ltd.

Manager	Title	Age	Since
Jung Chin Lin CEO	Chief Executive Officer	72	13/11/2018
Chia Chi Yang DFI	Director of Finance/CFO	-	01/02/2022
June Kuo Kuo CTO	Chief Tech/Sci/R&D Officer	-	29/06/2021
Sabrina Yeh PRN	Corporate Officer/Principal	-	-
Todd Ban PRN	Corporate Officer/Principal	-	-

See LUMOSA THERAPEUTICS CO., LTD. governance

Composition of the Board of Directors: Lumosa Therapeutics Co., Ltd.

Director	Title	Age	Since
Wan Lai Cheng BRD	Director/Board Member	-	25/07/2014
Jung Chin Lin CHM	Chairman	72	16/09/2011
I Hsiung Chang BRD	Director/Board Member	-	26/01/2016
Su Chi Wang BRD	Director/Board Member	-	25/07/2014
Hai Yi Ma BRD	Director/Board Member	-	07/07/2021
Te Fu Hsieh CHM	Chairman	-	22/09/2011
Hsueh Ling Wang BRD	Director/Board Member	-	03/07/2006
Chih Hsiung Wu BRD	Director/Board Member	-	14/06/2018
Chih Yung Chin BRD	Director/Board Member	-	27/06/2019
I Chi Kao BRD	Director/Board Member	-	14/06/2018

Composition of the Board of Directors

Shareholders: Lumosa Therapeutics Co., Ltd.

Name	Stocks	%	Valuation
CENTER LABORATORIES, INC. 34.42 %	5,77,76,874	34.42 %	225 M NT$
Yucheng Management Consultant Co. Ltd. 0.6275 %	10,53,218	0.6275 %	4 M NT$
Te Fu Hsieh 0.29 %	4,86,724	0.29 %	2 M NT$
Wan Lai Cheng 0.2891 %	4,85,295	0.2891 %	2 M NT$
Hsueh Ling Wang 0.2827 %	4,74,511	0.2827 %	2 M NT$

List of LUMOSA THERAPEUTICS CO., LTD. shareholders

Company details: Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

No. 3-2, Yuanqu Street

115 03, Taipei

http://www.lumosa.com.tw

address Lumosa Therapeutics Co., Ltd.(6535)

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LUMOSA THERAPEUTICS CO., LTD.	-1.39%	-9.75%	-35.84%	+71.22%	57Cr
ARGENX SE	+1.63%	+6.45%	+53.20%	+109.68%	5.48TCr
WUXI APPTEC CO., LTD.	+0.03%	-1.80%	+49.57%	+43.94%	4.33TCr
BIONTECH SE	+2.81%	-1.00%	-15.90%	-19.22%	2.18TCr
INSMED INCORPORATED	+5.32%	-7.87%	-1.34%	+395.72%	1.99TCr
WUXI BIOLOGICS (CAYMAN) INC.	+0.81%	-8.38%	+12.77%	-33.24%	1.57TCr
GENMAB A/S	+0.53%	+2.08%	+8.89%	-40.13%	1.53TCr
EXELIXIS, INC.	+1.13%	+1.26%	+28.29%	+178.42%	1.32TCr
PHARMAESSENTIA CORPORATION	-5.27%	+3.89%	+90.88%	+208.02%	1.16TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.74%	-1.05%	+12.88%	-	1.19TCr
Average	+0.39%	-1.26%	+20.34%	+101.60%	2.08TCr
Weighted average by Cap.	+1.03%	+1.14%	+31.65%	+97.15%